GLP-1 drugs like Ozempic are transforming weight loss and diabetes management. But no good deed goes unpunished, and the ...

While reduced bone density can raise the risk of osteoporosis, a scientist and author has shared the risks of losing muscle ...

According to leaders in obesity and nutrition research, following these key nutrition guidelines will make the most of GLP-1 ...

Ellie Crabtree, 22, from Cumbria, fell into a trap of emotional eating while caring for her father, Geoff, 59, was diagnosed ...

Doctors have warned users of medicines such as Ozempic Wegovy and Mounjaro about an irreversible potential side effect ...

Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

According to the Mayo Clinic, most weight loss occurs within the first four to five months of use. Long-term use of weight loss drugs can lead to sustained weight decreases and improvements in overall ...

Due to its role in managing diabetes, Ozempic, the brand name for the medication semaglutide, is gaining a lot of attention.

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The US Food and Drug Administration (FDA) ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...